On December 11, recombinant carboxypeptidase G2 for injection, a new class 1 biological product developed by our company, took part in the 89th item roadshow of Guangdong Yigu Open Day.

On August 9, 2019, the bio-pharmaceutical innovation service alliance of chongqing liangjiang new district was officially launched

At the symposium, 20 private enterprise representatives from chongqing xiian pharmaceutical co., LTD., zhifei biological products co., LTD., longxin group, etc., made speeches one after another.

Experience adventure safety Lin hai, challenge the limit ego psychology.

At present, the company is actively promoting clinical research and industrialization development. This product after, can greatly reduce cost, greatly improves the patient to a drug accessibility.